The Increasing Importance of Rigorous Real-World Evidence.
作者信息
Yang David D, Nguyen Paul L
机构信息
Department of Radiation Oncology, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
Harvard Radiation Oncology Program, Boston, MA, USA.
出版信息
JNCI Cancer Spectr. 2022 Aug 10;6(4). doi: 10.1093/jncics/pkac051.
Abstract
摘要
相似文献
1
The Increasing Importance of Rigorous Real-World Evidence.
JNCI Cancer Spectr. 2022 Aug 10;6(4). doi: 10.1093/jncics/pkac051.
2
Rivaroxaban real-world evidence: Validating safety and effectiveness in clinical practice.
Thromb Haemost. 2016 Sep 28;116(Suppl. 2):S13-S23. doi: 10.1160/TH16-06-0485. Epub 2016 Sep 14.
3
Real-world experiences with generating real-world evidence: Case Studies from PCORI's pragmatic clinical Studies program.
Contemp Clin Trials. 2020 Nov;98:106171. doi: 10.1016/j.cct.2020.106171. Epub 2020 Oct 7.
4
An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting.
Expert Opin Drug Saf. 2023 Jan-Jun;22(5):373-380. doi: 10.1080/14740338.2023.2219892. Epub 2023 May 29.
5
[Real-world data studies of medical products in the context of special healthcare policy: study designs and key considerations].
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Jul 10;42(7):1306-1311. doi: 10.3760/cma.j.cn112338-20210201-00085.
6
Association of thrombopoietin-related drugs with thromboembolic events: Mendelian randomization and a real-world study.
Ther Adv Drug Saf. 2024 Jan 27;15:20420986231224236. doi: 10.1177/20420986231224236. eCollection 2024.
7
Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices: A Landscape Assessment.
Value Health. 2021 Dec;24(12):1792-1798. doi: 10.1016/j.jval.2021.07.003. Epub 2021 Aug 18.
8
Modelling the Long-Term Health Outcome and Costs of Thrombectomy in Treating Stroke Patients with Large Ischaemic Core: Comparison between Clinical Trials and Real-World Data.
Cerebrovasc Dis. 2023;52(2):137-144. doi: 10.1159/000525806. Epub 2022 Dec 14.
9
Rigorous Criteria for the Collapse of Nonlinear Cooperative Networks.
Phys Rev Lett. 2023 Mar 3;130(9):097401. doi: 10.1103/PhysRevLett.130.097401.
10
Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence.
Ther Innov Regul Sci. 2020 Mar;54(2):303-307. doi: 10.1007/s43441-019-00058-6. Epub 2020 Jan 6.
引用本文的文献
1
Revolutionizing Immunotherapy: Unveiling New Horizons, Confronting Challenges, and Navigating Therapeutic Frontiers in CAR-T Cell-Based Gene Therapies.
Immunotargets Ther. 2024 Aug 27;13:413-433. doi: 10.2147/ITT.S474659. eCollection 2024.
2
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.
Target Oncol. 2023 Jul;18(4):559-570. doi: 10.1007/s11523-023-00978-2. Epub 2023 Jun 27.
本文引用的文献
1
Real-World Evidence Prediction of a Phase IV Oncology Trial: Comparative Degarelix vs Leuprolide Safety.
JNCI Cancer Spectr. 2022 Aug 10;6(4). doi: 10.1093/jncics/pkac049.
2
Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement.
J Clin Oncol. 2022 Jul 1;40(19):2163-2171. doi: 10.1200/JCO.22.00754. Epub 2022 May 19.
3
Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment.
JAMA Netw Open. 2021 Oct 1;4(10):e2130587. doi: 10.1001/jamanetworkopen.2021.30587.
4
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
Circulation. 2021 Oct 19;144(16):1295-1307. doi: 10.1161/CIRCULATIONAHA.121.056810. Epub 2021 Aug 30.
5
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study Design.
JACC CardioOncol. 2020 Mar 17;2(1):70-81. doi: 10.1016/j.jaccao.2020.01.004. eCollection 2020 Mar.
6
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
N Engl J Med. 2020 Jun 4;382(23):2187-2196. doi: 10.1056/NEJMoa2004325. Epub 2020 May 29.
7
Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
JAMA Netw Open. 2020 Mar 2;3(3):e201839. doi: 10.1001/jamanetworkopen.2020.1839.
8
Comparison of Population-Based Observational Studies With Randomized Trials in Oncology.
J Clin Oncol. 2019 May 10;37(14):1209-1216. doi: 10.1200/JCO.18.01074. Epub 2019 Mar 21.
9
Real-World Evidence - What Is It and What Can It Tell Us?
N Engl J Med. 2016 Dec 8;375(23):2293-2297. doi: 10.1056/NEJMsb1609216.
10
Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist.
Eur Urol. 2014 Mar;65(3):565-73. doi: 10.1016/j.eururo.2013.10.032. Epub 2013 Nov 1.
Zotero 插件